![]() |
|
|
4 Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada T6G 2P5; 5 The Research Institute, The Hospital for Sick Children, Toronto, ON, Canada M5G 1X8; and the 6 Departments of Paediatrics and Nutritional Science, University of Toronto, Toronto, ON, Canada M5G 1X8
* To whom correspondence should be addressed. E-mail: ron.ball{at}ualberta.ca.
Differences in lysine and arginine requirements among various species such as omnivores (humans, pigs, rats, dogs), carnivores (cats), herbivores (rabbits, horses), ruminants (cattle), poultry, and fish, are covered in detail in this article. Although lysine is classified as an indispensable amino acid across species, the classification of arginine as either an indispensable or dispensable amino acid is more ambiguous because of differences among species in rates of de novo arginine synthesis. Because lysine is most often the limiting amino acid in the diet, its requirement has been extensively studied. By use of the ideal protein concept, the requirements of the other indispensable amino acids can be extrapolated from the lysine requirement. The successful use of this concept in pigs is compared with potential application of the ideal protein concept in humans. The current dietary arginine requirement varies widely among species, with ruminants, rabbits, and rats having relatively low requirements and carnivores, fish, and poultry having high requirements. Interspecies differences in metabolic arginine utilization and reasons for different rates of de novo arginine synthesis are reviewed in detail, as these are the primary determinants of the dietary arginine requirement. There is presently no dietary requirement for humans of any age, although this needs to be reassessed, particularly in neonates. A thorough understanding of the factors contributing to the lysine and arginine requirements in different species will be useful in our understanding of human amino acid requirements.
This article has been cited by other articles:
![]() |
G. C Ligthart-Melis, M. C. van de Poll, M. A. Vermeulen, P. G Boelens, M P. van den Tol, C. van Schaik, J.-P. De Bandt, N. E. Deutz, C. H. Dejong, and P. A. van Leeuwen Enteral administration of alanyl-[2-15N]glutamine contributes more to the de novo synthesis of arginine than does intravenous infusion of the dipeptide in humans Am. J. Clinical Nutrition, July 1, 2009; 90(1): 95 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Pencharz, R. Elango, and R. O. Ball An Approach to Defining the Upper Safe Limits of Amino Acid Intake J. Nutr., October 1, 2008; 138(10): 1996S - 2002S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kimura, A. G. Renwick, M. Kadowaki, and L. A. Cynober The 7th Workshop on the Assessment of Adequate Intake of Dietary Amino Acids: Summary of General Discussion J. Nutr., October 1, 2008; 138(10): 2050S - 2052S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Baker Animal Models in Nutrition Research J. Nutr., February 1, 2008; 138(2): 391 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Baker Lysine, Arginine, and Related Amino Acids: An Introduction to the 6th Amino Acid Assessment Workshop J. Nutr., June 1, 2007; 137(6): 1599S - 1601S. [Abstract] [Full Text] [PDF] |
||||